About Careers Internship MedBlog Contact us

Kamal Nath Hails Court Verdict on Novaratis Patent Challenge

by VR Sreeraman on August 8, 2007 at 3:39 PM
Font : A-A+

Kamal Nath Hails Court Verdict on Novaratis Patent Challenge

Union Commerce Minister Kamal Nath has welcomed the Madras High Court's verdict of quashing Swiss pharma major Novartis' challenge to a patent law.

"Only one company had raised the issue. From the time the law was made, for the past two years, no one had raised any objections that it is not WTO compliant," Nath said on the sidelines of signing an agreement with Switzerland on intellectual property rights.


Nath said time had proved that the Indian law that denied patents for minor improvements to known drugs did not lead to any increase in prices.

"When this law was made, I had told in the Parliament that prices will not rise. It has been two years, and time is the biggest witness that the prices have not risen because of the law," he said.

The court rejected the challenge, saying it had no jurisdiction on whether Indian patent laws complied with intellectual property rules set by the WTO, as Novartis had questioned.

Novartis is expected to make a statement soon on the court order.

Novartis had filed a similar case against the South African Government in 2001, which tried to roll out HIV anti-retro viral drugs in its own country by granting licenses.

The Swiss company has said the Indian patent system stifles innovation.

Critics of Novartis say changes to the law would affect the supply of affordable anti-AIDS drugs from India, one of the biggest makers of generic drugs.

Novartis had moved the Madras High Court against a law that blocks the patenting of minor improvements in known molecules.

The Swiss pharmaceutical firm argued tightening of intellectual property laws would increase investment for developing more drugs.

Source: ANI


Latest Drug News

AstraZeneca's Liver Cancer Drug Approved by CDSCO in India
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
 FDA Issues Warning About Compounded Diabetes Drug Semaglutide Products
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Kamal Nath Hails Court Verdict on Novaratis Patent Challenge Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests